ClinicalTrials.Veeva

Menu

Effect of APC and Epo on the Inflammatory Response During Sepsis

L

Lawson Health Research Institute

Status

Completed

Conditions

Systemic Inflammation
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT00229034
11652E
R-05-382

Details and patient eligibility

About

An observational study to determine the effect of APC and Epo in reducing the systemic inflammatory response during severe sepsis.

Full description

An observational study to determine the effect of APC and Epo in reducing the systemic inflammatory response during severe sepsis. Patients already prescribed either drug will be enrolled. The microcirculation of the sublingual vascular bed will be observed with a microscope to detect the alterations in the inflammatory response.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients in the ICU in severe septic shock undergoing APC and/or Epo treatment

Exclusion criteria

  • any severe comorbid conditions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems